E
VYNE Therapeutics Inc. VYNE
$1.43 -$0.45-23.94% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Total Cash And Short-Term Investments -34.03% 354.33% 278.51% 184.48% 201.71%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 9.98% 87.78% 178.11% 59.99% 15.48%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -12.96% -31.34% -19.40% -19.40%
Total Current Assets -32.85% 319.94% 264.89% 173.22% 150.72%

Total Current Assets -32.85% 319.94% 264.89% 173.22% 150.72%
Net Property, Plant & Equipment -0.48% -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 49.31% 44.70% 36.05% -43.20% -38.99%
Total Assets -31.51% 295.48% 247.16% 159.98% 139.67%

Total Accounts Payable 63.17% 456.70% 289.65% 26.24% -30.47%
Total Accrued Expenses 144.54% 26.27% 11.76% -69.50% -17.59%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -13.91% -- -- -- --
Total Finance Division Other Current Liabilities 52.00% -- 79.63% -- -16.51%
Total Other Current Liabilities 52.00% -- 79.63% -- -16.51%
Total Current Liabilities 96.59% 96.33% 84.41% -7.83% -19.34%

Total Current Liabilities 96.59% 96.33% 84.41% -7.83% -19.34%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- 0.00% --
Total Liabilities 65.58% 63.12% 53.23% -5.96% -4.23%

Common Stock & APIC 0.41% 12.34% 12.37% 12.39% 12.41%
Retained Earnings -5.76% -4.96% -4.19% -4.35% -4.32%
Treasury Stock & Other -23.08% -- -- -- --
Total Common Equity -41.30% 452.26% 333.47% 215.43% 184.39%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -41.30% 452.26% 333.47% 215.43% 184.39%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -41.30% 452.26% 333.47% 215.43% 182.48%